Information  X 
Enter a valid email address

Company Name matching 'Telix Pharmaceuticals Limited'

Date
Time Source
Company
Announcement
21 Mar 2022 10:41 pm GNW   Telix Pharmaceuticals Limited Telix Radiopharmaceutical Production Facility Buildout Commences
  5:28 am GNW   Telix Pharmaceuticals Limited EAU Updates Guidance for PSMA-PET Imaging
08 Feb 2022 10:27 pm GNW   Telix Pharmaceuticals Limited Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement
27 Jan 2022 9:41 pm GNW   Telix Pharmaceuticals Limited Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus
26 Jan 2022 9:51 pm GNW   Telix Pharmaceuticals Limited First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
25 Jan 2022 6:29 am GNW   Telix Pharmaceuticals Limited Raphaël Ortiz Joins Telix as Chief Operating Officer, EMEA
20 Dec 2021 9:45 pm GNW   Telix Pharmaceuticals Limited First Patient Dosed in Study of Targeted Alpha Therapy Candidate for Bladder Cancer
19 Dec 2021 9:47 pm GNW   Telix Pharmaceuticals Limited FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®
07 Dec 2021 10:42 pm GNW   Telix Pharmaceuticals Limited Telix and NUCLIBER Sign Distribution Agreement for Prostate Cancer Imaging in Spain
01 Nov 2021 11:25 pm GNW   Telix Pharmaceuticals Limited Australian TGA Approves Illuccix® for Prostate Cancer Imaging
18 Oct 2021 6:21 am GNW   Telix Pharmaceuticals Limited First Cyclotron Removed from Seneffe Production Facility by SCK CEN
04 Oct 2021 10:34 pm GNW   Telix Pharmaceuticals Limited First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
  8:17 am GNW   Telix Pharmaceuticals Limited Telix Establishes Commercial Hub in Geneva, Switzerland
12 Sep 2021 11:36 pm GNW   Telix Pharmaceuticals Limited Telix and Radius Sign Italian Distribution Agreement for Prostate Cancer Imaging
09 Sep 2021 6:34 am GNW   Telix Pharmaceuticals Limited Telix In-Licences Novel Tumour Microenvironment PET Tracer
18 Aug 2021 2:26 am GNW   Telix Pharmaceuticals Limited Two New Studies to Explore Telix Assets in Breast Cancer Theranostics
  2:03 am GNW   Telix Pharmaceuticals Limited Telix and Merck to Commence Pan-Cancer Clinical Combination Studies
17 Aug 2021 12:55 am GNW   Telix Pharmaceuticals Limited Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia
25 May 2021 1:58 am GNW   Telix Pharmaceuticals Limited TLX66 Meets Study Objectives in Patients with AL Amyloidosis
10 May 2021 11:56 pm GNW   Telix Pharmaceuticals Limited Telix and Monrol Expand Alliance to Include Lutetium Supply
  12:13 am GNW   Telix Pharmaceuticals Limited Telix Commences Phase III Clinical Trial of Prostate Cancer Therapy
03 May 2021 12:14 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals Appoints Mr. Richard Valeix as EMEA President
20 Apr 2021 3:32 pm GNW   Telix Pharmaceuticals Limited The NOBLE Registry – An International Collaboration to Develop iPSMA SPECT Imaging for Prostate Cancer
16 Feb 2021 6:05 am GNW   Telix Pharmaceuticals Limited Czech Republic First European Country to Grant National Authorisation for the Use of Telix’s Prostate Cancer Imaging Product
30 Nov 2020 2:07 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine
02 Nov 2020 4:10 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market
22 Oct 2020 6:00 am GNW   Telix Pharmaceuticals Limited First Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product in Turkey
03 Sep 2020 1:00 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals Enters Strategic Collaboration with Varian Medical Systems for Advanced Prostate Imaging
01 May 2020 1:14 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals submits European marketing authorisation application for prostate cancer imaging product
05 Aug 2019 1:00 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals and German Cancer Research Center (DKFZ) Enter into Collaboration and Option Agreement for Image-Guided Prostate Surgery
02 Jul 2019 1:00 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals and PI Medical Sign Distribution Agreement for the Netherlands
13 Jun 2019 12:54 pm GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals and Eczacibasi-Monrol Sign Manufacturing and Distribution Agreement
24 Jan 2019 12:15 am GNW   Telix Pharmaceuticals Limited Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership
26 Nov 2018 7:00 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals Acquires Advanced Nuclear Medicine Ingredients (ANMI) SA
14 Oct 2018 11:00 pm GNW   Telix Pharmaceuticals Limited Telix and ANMI Expand PSMA Imaging Partnership
09 Oct 2018 11:00 pm GNW   Telix Pharmaceuticals Limited GenesisCare and Telix Enter into Strategic Collaboration Agreement to Accelerate Patient Access to New Treatments
11 Sep 2018 12:30 am GNW   Telix Pharmaceuticals Limited Telix Completes Acquisition of Atlab for Prostate Cancer Program
16 Apr 2018 1:27 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership
26 Mar 2018 1:00 pm GNW   Telix Pharmaceuticals Limited Drug Master File for Prostate Imaging Product Filed with the FDA
14 Mar 2018 11:00 pm GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals and Radboud University Medical Centre Conclude Clinical Collaboration Agreement
15 Nov 2017 1:00 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange
08 Nov 2017 11:33 pm GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals Limited Successfully Completes $50 Million Oversubscribed Initial Public Offering
24 Oct 2017 12:00 am GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals and ANMI Partner for Prostate Cancer Imaging
23 Oct 2017 10:00 pm GNW   Telix Pharmaceuticals Limited Telix Pharmaceuticals Limited Launches $50 Million Underwritten Initial Public Offering (ASX: TLX)


Company Announcements Archive »


a d v e r t i s e m e n t